Evidence map›Paper›PMID 36144575›Full record

ArticleMolecules (Basel, Switzerland)2022

A Peptide HEPFYGNEGALR from

Qiliang Zhu, Huiling Zhuo, Lamei Yang, Haohong Ouyang, Jun Chen, Bing Liu, Hongliang Huang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Roles of the Keap1/Nrf2 pathway and mitophagy in liver diseases.Journal of Zhejiang University. Science. B · 2025
    Review
  6. Review
  7. Review
  8. Efficacy ofHeliyon · 2024
    Article
  9. Patterns of the Nutrients and Metabolites inFoods (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qiliang ZhuSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Huiling ZhuoSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Lamei YangSchool of Nursing, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Haohong OuyangSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Jun ChenSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Bing LiuSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Hongliang HuangSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0003-0887-5621
Guangdong Pharmaceutical University · CN

Funding

Guangzhou key laboratory of construction and application of new drug screening model systems 201805010006Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province 2017KSYS002
6 · The paper itself

Abstract

Liver-related disease caused by alcohol is a frequent disorder of the hepatic tract. Heavy consumption of alcohol in a short period causes oxidative damage to the liver. Sea cucumber is abundant in nutrients and its various extracts have been studied for antioxidant properties. One peptide was isolated and identified from

Indexed as

Liver Diseases, AlcoholicStichopusAnimalsAntioxidantsEthanolLiverMaleMiceMice, Inbred C57BLNF-E2-Related Factor 2NF-kappa BOxidative StressPeptidesAntioxidantsEthanolNF-E2-Related Factor 2NF-kappa BPeptidesacute alcoholic liver injuryautophagyoxidative stresssea cucumber

Identifiers

PMID36144575
PMCPMC9503860
OpenAlexW4295213468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.